logo

Novavax Inc. (NVAX)



Trade NVAX now with
  Date
  Headline
10/15/2019 7:15:20 AM Novavax Initiates Pivotal Phase 3 Clinical Trial Of NanoFlu Influenza Vaccine In Older Adults
6/27/2019 7:16:31 AM Novavax Confirms Accelerated Approval Pathway Available For Licensure Of NanoFlu
1/3/2019 4:07:35 PM Novavax Announces Positive Phase 2 NanoFlu Results In Older Adults
11/7/2018 4:10:20 PM Novavax Q3 Loss Per Share $0.12 Vs Loss $0.15 Last Year
11/1/2018 4:10:23 PM Novavax Appoints Rachel King To Board Of Directors
9/25/2018 7:00:49 AM Novavax Begins Phase 2 Dose And Formulation Confirmation Clinical Trial In Older Adults Of NanoFlu
  
 
>